期刊文献+

多色荧光原位杂交技术检测结直肠癌早期染色体改变的研究 被引量:1

Research of multicolor fluorescence in situ hybridization in the early diagnosis of colorectal cancer
原文传递
导出
摘要 目的分析我国结直肠癌(CRC)及结直肠腺瘤染色体畸变情况,探讨通过多色荧光原位杂交(M—FISH)技术检测染色体变化,用于CRC早期诊断及评估腺瘤恶性变倾向的可行性和有效性。方法选择7、8、12和20号染色体探针应用M—FISH技术检测161例患者的183份结直肠病变组织,包括65份腺瘤组织、19份癌旁腺瘤组织和99份腺癌组织。分析结直肠腺癌和腺瘤与临床病理参数之间的关系。结果7、8、12和20号染色体在腺癌组织中有较高的增益畸变率,分别为82.1%(55/67)、70.1%(47/67)、60.9%(56/92)和72.8%(67/92);在癌旁腺瘤组织亦有较高的增益畸变率,分别为76.5%(13/17)、41.2%(7/17)、50%(9/18)和72.2%(13/18);7号和20号染色体增益畸变同时出现在同一个患者的腺癌与腺瘤标本中的频率较高。结论7、8、12和20号染色体在腺癌及腺瘤组织中均存在较高的染色体数目畸变率;其中7号与20号染色体增益畸变有可能成为CRC早期预警标志。M—FISH技术检测可能有助于CRC的早期诊断。 Objective To reveal the aberrations of some chromosomes in colorectal cancer (CRC) and its premalignant lesions-colorectal adenoma by using multicolor fluorescence in situ hybridization (M-FISH), so as to explore the feasibility and effectiveness of M-FISH in the early diagnosis of CRC and the evaluation of tendency of malignant transformation of the colorectal adenoma. Methods M-FISH was performed in 183 colorectal lesion biopsy specimens of 161 cases, which included 65 adenoma tissues, 19 adenoma tissues adjacent adenocarcinoma and 99 adenocarcinoma biopsy specimens. The relationship between chromosomal aberrations and clinicopathologic parameters was also analyzed. Results The copy number gains of chromosomes 7, 8, 12 and 20 were 82.1%(55/67), 70.1%(47/67), 60.9 %(56/92) and 72.8 %(67/92) in the adenocarcinoma tissues, 76.5 %(13/17), 41.2 %(7/17), 50 %(9/18) and 72.2 %(13/18) in the adenoma tissues adjacent adenocarcinomas. Chromosomal 7 and 20 presented high frequently consistent alterations in adenoma and adenocarcinoma of the same patients. Conclusion High aneuploidy rate of chromosomes 7, 8, 12 and 20 are detected in both colorectal adenocarcinomas and adenomas. Aneuploidy rate of Chromosome 7 and 20 may be early warning signs of colorectal cancer. M-FISH may be helpful in the early diagnosis of colorectal adenocarcinomas.
出处 《肿瘤研究与临床》 CAS 2009年第9期584-587,共4页 Cancer Research and Clinic
基金 国家自然科学基金(30630067) 北京市科技计划重大专项(D0905001040331)
关键词 腺瘤 早期诊断 原位杂交 荧光 染色体畸变 Adenoma Early diagnosis Insitu hybridization, fluoressence Chromosome aberrations
  • 相关文献

参考文献11

  • 1刘艳辉,张国淳.乳腺癌组织HER-2的荧光原位杂交和免疫组化联合检测的评价[J].循证医学,2006,6(2):81-83. 被引量:10
  • 2Dybdal N, Leiberman G, Anderson S, et al. Determination of HER2 gene amplification by fluorescence in situ hybridization and concordance with the clinical trials immunohistochemical assay in women with metastatic breast cancer evaluated for treatment with trastuzumab. Breast Cancer Res Treat, 2005, 93:3-11.
  • 3Marin-Aguilera M, Menqual L, Ribal M J, et al. Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder eancer. Cancer Genet Cytogenet, 2007, 173: 131-135.
  • 4Persons DL, Croughan WS, Berelli KA, et al. Interphase cytogenetics of esophageal adenocarcinoma and precursor lesions. Cancer Genet Cytogenet, 1998, 106:11-17.
  • 5Kruger S, Mess F, Bohle A, et al. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder. Int J Oncol, 2003, 23: 41-48.
  • 6Oliver-Bonet M, Benet J, Martin RH. Studying meiosis: a review of FISH and M-FISH techniques used in the analysis of meiotic processes in humans. Cytogenet Genomc Res, 2006, 114:312-318.
  • 7杨玲,李连弟,陈育德,D.M.Parkin.中国2000年及2005年恶性肿瘤发病死亡的估计与预测[J].中国卫生统计,2005,22(4):218-221. 被引量:336
  • 8De' Angelis PM, Stokke J, Beigi M, et al. Prognostic significance of recurrent chromosomal aberrations detected by comparative genomic hybridization in sporadic colorectal cancer. Int J Colorectal Dis, 2001, 16: 38-45.
  • 9Bardi G, Sardi G, Sukhikh T, et al. Karyotypic characterization of colorectal adenocarcinomas. Genes Chromosomes Cancer, 1995, 12: 97-109.
  • 10Ried T, Knutzen R, Steinbeok R, et al. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer, 1996, 15: 234-245.

二级参考文献25

  • 1李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:226
  • 2李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 3Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide, Version 2.0. IARC Cancer Base No 5. Lyon, IARCPress, 2004.
  • 4Yang L, Parkin DM, Li LD, et al. A comparison of the sources ofeancer mortality in China. Cancer Causes Conhol, 2004, 15(7) : 1581-7.
  • 5International Agency for Research on Cancer. Cancer Mortality Database. http://www-deodb, iarc. fr/who/menu, hun.
  • 6Parkin DM, Whelan SL, Ferlay J, et al. Cancer in Five Continents Vol.VIII. IARC Scientific Publication No. 155, Lyon, FraQce: IARC-Press; 2002.
  • 7United Nations, Population Division (2003) World Population Prospects: The 2002 Revision. Population Database. http://esa, un.org/unpp.
  • 8Yang L, Parkin DM, Li LD, et al. Time Trends in Cancer mortality in China: 1987-1999. International J Cancer, 2003,106(5) :771-83).
  • 9Yang L, Parkin DM, Li LD, et al. Estimation and projection of the national profile of cancer mortality in China: 1991 - 2005. British Journal of Cancer, 2004, 90:2157-2166.
  • 10Yang L, Parkin DM, Ferlay J, et al. Estimates of cancer in cidenee in China for 2000 and projection for 2005. Cancer Epidemiology, Biomarkers & Prevention. 2005, 14( 1 ) : 243-250.

共引文献344

同被引文献42

  • 1Jcmal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
  • 2Plaks V, Koopman CD, Werb Z. Cancer. Circulating tumor cells [J]. Science, 2013, 341(6151): 1186-1188.
  • 3Coumans FAW, van Dalum G, Beck M, et aL Filter characteristics influencing circulating tumor cell enrichment from whole blood[J]. PloS One, 2013, 8(4): e61770.
  • 4Cohen S J, Alpaugh RK, Gross S, et al. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer[J]. Clinical colorectal cancer, 2006, 6(2): 125-132.
  • 5Hammarstrtim S. The carcinoembryenic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues[J]. Semin Cancer Biol, 1999, 9: 67-81.
  • 6Aquino A, Prete SP, Balduzzi A, eta/. Treatment of peripheral blood withstaurosporine increases detection of circulating tumor cells[J]. Int J Cancer 2002 100: 119-121.
  • 7Gauthier LR, Granotier C, Sofia JC, et al. Detection of circulating careinomacells by telomerase activity[J]. Br J Cancer, 2001, 84: 631-635.
  • 8Hardingham JE, Kotasek D, Sage RE, et al. Detection of circulating tumor cells in eoloreetal cancer by immunobead-PCRis a sensitive prognostic marker for relapse of disease[J]. Mol Med, 1995, 1: 789-794.
  • 9Yang M J, Chiu HH, Wang HM, et al. Enhancing detection of circulating tumorcells with activating KRAS oncogene in patientswith colorectal cancer byweightedchemiluminescent membrane array method[J]. Ann SurgOncol, 2010, 17: 624-633.
  • 10K6nigsberg R, Gneist M. Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods[J]. Cancer Lett, 2010, 293(1): 117-123.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部